41
TÍTULO: Concentration‐Dependent Clinical and Prognostic Importance of High‐Sensitivity Cardiac Troponin T in Heart Failure and a Reduced Ejection Fraction and the Influence of Empagliflozin: the EMPEROR‐Reduced Trial
AUTORES: Milton Packer; James L Januzzi; Joao Pedro Ferreira ; Stefan D Anker; Javed Butler; Gerasimos Filippatos; Stuart J Pocock; Martina Brueckmann; Waheed Jamal; Daniel Cotton; Tomoko Iwata; Faiez Zannad;
PUBLICAÇÃO: 2021, FONTE: European Journal of Heart Failure
INDEXADO EM: CrossRef: 30
42
TÍTULO: New-onset atrial fibrillation in patients with worsening heart failure and coronary artery disease: an analysis from the COMMANDER-HF trial  Full Text
AUTORES: João Pedro Ferreira ; John G Cleland; Carolyn S P Lam; Stefan D Anker; Mandeep R Mehra; Dirk J van Veldhuisen; William M Byra; David A LaPolice; Barry Greenberg; Faiez Zannad;
PUBLICAÇÃO: 2021, FONTE: Clinical Research in Cardiology
INDEXADO EM: CrossRef: 5
43
TÍTULO: Regional and ethnic influences on the response to empagliflozin in patients with heart failure and a reduced ejection fraction: the EMPEROR-Reduced trial
AUTORES: Carolyn S P Lam; João Pedro Ferreira ; Egon Pfarr; David Sim; Hiroyuki Tsutsui; Stefan D Anker; Javed Butler; Gerasimos Filippatos; Stuart J Pocock; Naveed Sattar; Subodh Verma; Martina Brueckmann; Janet Schnee; Daniel Cotton; Faiez Zannad; Milton Packer;
PUBLICAÇÃO: 2021, FONTE: European Heart Journal
INDEXADO EM: CrossRef: 39
44
TÍTULO: Novel biomarker-driven prognostic models to predict morbidity and mortality in chronic heart failure: the EMPEROR-Reduced trial
AUTORES: Pocock, Stuart J.; Ferreira, Joao Pedro ; Gregson, John; Anker, Stefan D.; Butler, Javed; Filippatos, Gerasimos; Gollop, Nicholas D.; Iwata, Tomoko; Brueckmann, Martina; Januzzi, James L., Jr.; Voors, Adriaan A.; Zannad, Faiez; Packer, Milton;
PUBLICAÇÃO: 2021, FONTE: EUROPEAN HEART JOURNAL, VOLUME: 42, NÚMERO: 43
INDEXADO EM: WOS CrossRef: 35
45
TÍTULO: Influence of endpoint definitions on the effect of empagliflozin on major renal outcomes in the EMPEROR-Preserved trial
AUTORES: Packer, M; Zannad, F; Butler, J; Filippatos, G; Ferreira, JP ; Pocock, SJ; Brueckmann, M; Zeller, C; Hauske, S; Anker, SD;
PUBLICAÇÃO: 2021, FONTE: EUROPEAN JOURNAL OF HEART FAILURE, VOLUME: 23, NÚMERO: 10
INDEXADO EM: WOS CrossRef: 24
46
TÍTULO: Prognostic Importance of NT-proBNP and Effect of Empagliflozin in the EMPEROR-Reduced Trial  Full Text
AUTORES: James L Januzzi; Faiez Zannad; Stefan D Anker; Javed Butler; Gerasimos Filippatos; Stuart J Pocock; João Pedro Ferreira ; Naveed Sattar; Subodh Verma; Ola Vedin; Janet Schnee; Tomoko Iwata; Dan Cotton; Milton Packer;
PUBLICAÇÃO: 2021, FONTE: Journal of the American College of Cardiology, VOLUME: 78, NÚMERO: 13
INDEXADO EM: CrossRef: 68
47
TÍTULO: Empagliflozin Improves Cardiovascular and Renal Outcomes in Heart Failure Irrespective of Systolic Blood Pressure  Full Text
AUTORES: Michael Böhm; Stefan D Anker; Javed Butler; Gerasimos Filippatos; João Pedro Ferreira ; Stuart J Pocock; Felix Mahfoud; Martina Brueckmann; Waheed Jamal; Anne Pernille Ofstad; Elke Schüler; Piotr Ponikowski; Christoph Wanner; Faiez Zannad; Milton Packer;
PUBLICAÇÃO: 2021, FONTE: Journal of the American College of Cardiology, VOLUME: 78, NÚMERO: 13
INDEXADO EM: CrossRef: 58
48
TÍTULO: Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes
AUTORES: Pitt, B; Filippatos, G; Agarwal, R; Anker, SD; Bakris, GL; Rossing, P; Joseph, A; Kolkhof, P; Nowack, C; Schloemer, P; Ruilope, LM;
PUBLICAÇÃO: 2021, FONTE: NEW ENGLAND JOURNAL OF MEDICINE, VOLUME: 385, NÚMERO: 24
INDEXADO EM: Scopus WOS CrossRef: 120 Unpaywall
49
TÍTULO: Heart Failure Association of the European Society of Cardiology update on sodium-glucose co-transporter 2 inhibitors in heart failure (an update on the sodium-glucose co-transporter 2 inhibitors in heart failure: beyond glycaemic control. A position paper of the Heart Failure Association of the European Society of Cardiology)  Full Text
AUTORES: Seferovic, PM; Fragasso, G; Petrie, M; Mullens, W; Ferrari, R; Thum, T; Bauersachs, J; Anker, SD; Ray, R; Cavusoglu, Y; Polovina, M; Metra, M; Ambrosio, G; Prasad, K; Seferovic, J; Jhund, PS; Dattilo, G; Celutkiene, J; Piepoli, M; Moura, B ; Chioncel, O; Ben Gal, T; Heymans, S; Jaarsma, T; Hill, L; Lopatin, Y; Lyon, AR; Ponikowski, P; Lainscak, M; Jankowska, E; Mueller, C; Cosentino, F; Lund, LH; Filippatos, GS; Ruschitzka, F; Coats, AJS; Rosano, GMC; ...Mais
PUBLICAÇÃO: 2020, FONTE: EUROPEAN JOURNAL OF HEART FAILURE, VOLUME: 22, NÚMERO: 11
INDEXADO EM: Scopus WOS
50
TÍTULO: Plasma D ‐dimer concentrations predicting stroke risk and rivaroxaban benefit in patients with heart failure and sinus rhythm: an analysis from the COMMANDER‐HF trial
AUTORES: João Pedro Ferreira ; Carolyn S.P Lam; Stefan D Anker; Mandeep R Mehra; Dirk J Veldhuisen; William M Byra; David A La Police; John G.F Cleland; Barry Greenberg; Faiez Zannad;
PUBLICAÇÃO: 2020, FONTE: European Journal of Heart Failure, VOLUME: 23, NÚMERO: 4
INDEXADO EM: CrossRef: 13
Página 5 de 7. Total de resultados: 61.